Yu-Sheng Wu

ORKAMBI-Mediated Rescue of Mucociliary Clearance in Cystic Fibrosis Primary Respiratory Cultures Is Enhanced by Arginine Uptake, Arginase Inhibition, and Promotion of Nitric Oxide Signaling to the Cystic Fibrosis Transmembrane Conductance Regulator Channel

Yu-Sheng Wu, Janet Jiang, Saumel Ahmadi et al. · Molecular Pharmacology · 2019 · 51 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

<i>SLC6A14</i> Is a Genetic Modifier of Cystic Fibrosis That Regulates <i>Pseudomonas aeruginosa</i> Attachment to Human Bronchial Epithelial Cells

Michelle Di Paola, Amber J. Park, Saumel Ahmadi et al. · mBio · 2017 · 50 citations · Full text

Life Sciences, Genetics, Microbiology +15

SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretion

Saumel Ahmadi, Sunny Xia, Yu-Sheng Wu et al. · eLife · 2018 · 42 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Lipophilicity of the Cystic Fibrosis Drug, Ivacaftor (VX-770), and Its Destabilizing Effect on the Major CF-causing Mutation: F508del

Stephanie Chin, Maurita Hung, Amy Won et al. · Molecular Pharmacology · 2018 · 41 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Extracted Triterpenes from Antrodia cinnamomea Reduce the Inflammation to Promote the Wound Healing via the STZ Inducing Hyperglycemia-Diabetes Mice Model

Yu-Sheng Wu, Shiu‐Nan Chen · Frontiers in Pharmacology · 2016 · 32 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17